Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Percentage of repondents |
|---|---|
| Allergies | 21.5% |
| Arthritis | 18.3% |
| High blood pressure | 17.2% |
| Diabetes | 15.9% |
| Chronic back pain | 12.4% |
| High cholesterol | 10.2% |
| Asthma | 9.6% |
| Anxiety disorder | 8.9% |
| Stomach or intestinal problems | 8% |
| Mood disorder | 7.8% |
| Hearing impairment | 6.9% |
| Dermatitis/atopic eczema | 5.5% |
| Thyroid | 5.2% |
| Cataracts | 4.3% |
| Heart disease | 4.2% |
| Anemia (chronic) | 4% |
| Blidness or serious vision problems | 3.8% |
| Kidney problems | 3.3% |
| Emphysema, chronic bronchitis, COPD | 2.5% |
| Osteoporosis | 2.4% |
| Learning disorder | 2.3% |
| ADD/ADHD* | 2.2% |
| Cancer | 2% |
| Speech or language difQiculties | 1.6% |
| Effects of stroke | 1.4% |
| Tuberculosis | 1.3% |
| Liver disease | 1.2% |
| Glaucoma | 1.1% |
| Hepatitis | 0.9% |
| Epilepsy | 0.6% |
| Neurological disease | 0.4% |
| Alzheimer's disease or other dementia | 0.3% |
| HIV/AIDS* | 0.2% |
| Autism spectrum disorder* | 0.1% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
March 2018
More information
Region
Canada
Survey time period
March 2015 to December 2016
Number of respondents
12,137 respondents
Age group
18 years and older
Special properties
253 communities
Supplementary notes
* High sampling variability, interpret with caution.
Citation formats
